Therapy on male delayed puberty caused by hypogonadotropic hypogonadism by combination of growth hormone and gonadotropin

WANG Yu; FAN Yu-ping; HU Ye; HUANG Wen-qiang; TENG Xiao-ming

doi:10.3969/j.issn.1006-0111.2013.05.010

Message Board

Respected readers, authors and reviewers, you can add comments to this page on any questions about the contribution, review, editing and publication of this journal. We will give you an answer as soon as possible. Thank you for your support!

Name

E-mail

Phone

Title

Content

Verification Code

Objective To evaluate the value and safety of combined therapy of growth hormone and gonadotropin on male delayed puberty caused by hypogonadotropic hypogonadism. Methods A retrospective analysis was undergoing in Shanghai First Maternity and Infant Hospital from 2010 Jun to 2012 May. 28 cases with male delayed puberty caused by hypogonadotropic hypogonadism were enrolled. The average age was (15.25±1.11) years. All the cases were given a combined therapy of human chorionic gonadotrophin, follicle stimulating hormone and growth hormone. After 3 months therapy, the growth condition such as sexual hormone levels, height, and volume of testis were recorded to inspect the treatment effect. Results All 28 cases had a follow-up visit. No short term complications occurred. The height and testosterone level was higher than which before therapy (P<0.05). And the volume of testis, follicle stimulating hormone and luteinizing hormone level were significantly higher than before the therapy. Conclusion Combined therapy of human chorionic gonadotrophin, follicle stimulating hormone and growth hormone could be a safe and effective method to treat male delayed puberty caused by hypogonadotropic hypogonadism.

Therapy on male delayed puberty caused by hypogonadotropic hypogonadism by combination of growth hormone and gonadotropin

Reproductive Medicine Center, Shanghai First Maternity and Infant Hospital, Tong-ji University School of Medicine, Shanghai 200040, China

Received Date: 2013-05-03

Rev Recd Date: 2013-07-31

Key words:

Abstract: Objective To evaluate the value and safety of combined therapy of growth hormone and gonadotropin on male delayed puberty caused by hypogonadotropic hypogonadism. Methods A retrospective analysis was undergoing in Shanghai First Maternity and Infant Hospital from 2010 Jun to 2012 May. 28 cases with male delayed puberty caused by hypogonadotropic hypogonadism were enrolled. The average age was (15.25±1.11) years. All the cases were given a combined therapy of human chorionic gonadotrophin, follicle stimulating hormone and growth hormone. After 3 months therapy, the growth condition such as sexual hormone levels, height, and volume of testis were recorded to inspect the treatment effect. Results All 28 cases had a follow-up visit. No short term complications occurred. The height and testosterone level was higher than which before therapy (P<0.05). And the volume of testis, follicle stimulating hormone and luteinizing hormone level were significantly higher than before the therapy. Conclusion Combined therapy of human chorionic gonadotrophin, follicle stimulating hormone and growth hormone could be a safe and effective method to treat male delayed puberty caused by hypogonadotropic hypogonadism.

HTML

Reference (7)

[1]	Silveira LF, MacColl GS, Bouloux PM. Hypogonadotropic hypogonadism[J]. Semin Reprod Med,2002, 20(4):327.
[2]	杨念钦, 王国民. HCG-FSH联合治疗低促性腺激素性性腺功能减退症29例报告[J]. 中国男科学, 2009, 23(12):39.
[3]	狄福松, 崔毓桂, 贾悦. 促性腺激素治疗男性低促性腺激素性性腺功能减退症的疗效评估[J]. 中华内科杂志,2005, 44(11):836.
[4]	Wang GM, O`Shaughnessy PJ, Chubb C, et al. Effects of insulin like growth factor-I on steroidogenic enzyme expression levels in mouse Leydig cells[J]. Endocrinology,2003, 144(11): 5058.
[5]	Warne DW, Decosterd G, Okada H, et al. A combined analysis of data to identify predictive factors for spermatogenesis in men with hypogonadotropic hypogonadism treated with recombinant human follicle-stimulating hormone and human chorionic gonadotropin[J]. Fertil Steril, 2009, 92:594.
[6]	Kanzaki M, Morris PL. Growth hormone regulates steroidogenic acute regulatory protein expression and steroidogenesis in Leydig cell progenitors[J]. Endocrinology,1999, 140(4):1681.
[7]	Zheng JX, Liu ZZ, Yang N. Deficiency of growth hormone receptor does not affect male reproduction in dwarf chickens[J]. Poult Sci,2007, 86(1):112.

Message Board

Therapy on male delayed puberty caused by hypogonadotropic hypogonadism by combination of growth hormone and gonadotropin

doi: 10.3969/j.issn.1006-0111.2013.05.010

Abstract

References

Proportional views

通讯作者: 陈斌, [email protected]

Article Metrics

Related

Proportional views